Form 8-K - Current report:
SEC Accession No. 0001140361-23-037246
Filing Date
2023-08-01
Accepted
2023-08-01 11:21:15
Documents
55
Period of Report
2023-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20056829_8k.htm   iXBRL 8-K 30817
2 EXHIBIT 99.1 brhc20056829_ex99-1.htm EX-99.1 94404
6 brhc20056829_ex99-1slide1.jpg GRAPHIC 86875
7 brhc20056829_ex99-1slide2.jpg GRAPHIC 380053
8 brhc20056829_ex99-1slide3.jpg GRAPHIC 153431
9 brhc20056829_ex99-1slide4.jpg GRAPHIC 124266
10 brhc20056829_ex99-1slide5.jpg GRAPHIC 46088
11 brhc20056829_ex99-1slide6.jpg GRAPHIC 196284
12 brhc20056829_ex99-1slide7.jpg GRAPHIC 175830
13 brhc20056829_ex99-1slide8.jpg GRAPHIC 158008
14 brhc20056829_ex99-1slide9.jpg GRAPHIC 125036
15 brhc20056829_ex99-1slide10.jpg GRAPHIC 124526
16 brhc20056829_ex99-1slide11.jpg GRAPHIC 46521
17 brhc20056829_ex99-1slide12.jpg GRAPHIC 205777
18 brhc20056829_ex99-1slide13.jpg GRAPHIC 177152
19 brhc20056829_ex99-1slide14.jpg GRAPHIC 38564
20 brhc20056829_ex99-1slide15.jpg GRAPHIC 172826
21 brhc20056829_ex99-1slide16.jpg GRAPHIC 126272
22 brhc20056829_ex99-1slide17.jpg GRAPHIC 177843
23 brhc20056829_ex99-1slide18.jpg GRAPHIC 196940
24 brhc20056829_ex99-1slide19.jpg GRAPHIC 40677
25 brhc20056829_ex99-1slide20.jpg GRAPHIC 176334
26 brhc20056829_ex99-1slide21.jpg GRAPHIC 206989
27 brhc20056829_ex99-1slide22.jpg GRAPHIC 105701
28 brhc20056829_ex99-1slide23.jpg GRAPHIC 230857
29 brhc20056829_ex99-1slide24.jpg GRAPHIC 156329
30 brhc20056829_ex99-1slide26.jpg GRAPHIC 136126
31 brhc20056829_ex99-1slide27.jpg GRAPHIC 190524
32 brhc20056829_ex99-1slide28.jpg GRAPHIC 221115
33 brhc20056829_ex99-1slide29.jpg GRAPHIC 172833
34 brhc20056829_ex99-1slide30.jpg GRAPHIC 170007
35 brhc20056829_ex99-1slide31.jpg GRAPHIC 30762
36 brhc20056829_ex99-1slide32.jpg GRAPHIC 142439
37 brhc20056829_ex99-1slide33.jpg GRAPHIC 99860
38 brhc20056829_ex99-1slide34.jpg GRAPHIC 201077
39 brhc20056829_ex99-1slide35.jpg GRAPHIC 115691
40 brhc20056829_ex99-1slide36.jpg GRAPHIC 198384
41 brhc20056829_ex99-1slide37.jpg GRAPHIC 206106
42 brhc20056829_ex99-1slide38.jpg GRAPHIC 176477
43 brhc20056829_ex99-1slide39.jpg GRAPHIC 176718
44 brhc20056829_ex99-1slide40.jpg GRAPHIC 211705
45 brhc20056829_ex99-1slide41.jpg GRAPHIC 238106
46 brhc20056829_ex99-1slide42.jpg GRAPHIC 137710
47 image00001.jpg GRAPHIC 110385
  Complete submission text file 0001140361-23-037246.txt   9331363

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocup-20230801.xsd EX-101.SCH 3865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20230801_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20230801_pre.xml EX-101.PRE 16044
49 EXTRACTED XBRL INSTANCE DOCUMENT brhc20056829_8k_htm.xml XML 4087
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 231130246
SIC: 2834 Pharmaceutical Preparations